T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis
about
Advances in HIV microbicide developmentMucosal Vaccination with Heterologous Viral Vectored Vaccine Targeting Subdominant SIV Accessory Antigens Strongly Inhibits Early Viral Replication.A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and primes for virus-amplified immunityRepeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxisAntiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected PersonsDistinct genital tract HIV-specific antibody profiles associated with tenofovir gel.Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalitiesHIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.New clinical trial designs for HIV vaccine evaluation.Turning the Tide Against HIV
P2860
Q26852858-1885986D-9A1F-4F04-B2C6-EB2AB5F2D4E4Q33603602-0044D049-CDE9-4C81-BD14-AFD26D7C00B2Q34399535-19E74ADB-E835-433D-87BC-3AAE080AE884Q35798274-BABF2429-43D4-4EEF-B6A2-17D05B4EB1BAQ36379277-83E0D768-6D1E-4025-9031-11B463F998AEQ36812840-A2CED0FE-CB16-48DF-9CB2-D1A21C1AD91EQ36844746-4E282A32-5B85-48D4-96F0-AA0190717963Q37069793-8F93E603-FF74-4A32-8C69-1875EC42DD98Q37258303-E32A10AD-6EA0-4E6D-AEF3-91C2C9899DC1Q37347345-2B6F3005-8A4E-4F9B-826C-E045AE30F8DDQ37412300-3AF3906E-721C-41B1-8AAA-6254DA75A5F9Q57902608-C58021E9-340A-42F0-9F62-4C1023E400B9
P2860
T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@ast
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@en
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@nl
type
label
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@ast
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@en
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@nl
prefLabel
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@ast
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@en
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@nl
P2093
P2860
P3181
P1433
P1476
T cell chemo-vaccination effec ...... oral pre-exposure prophylaxis
@en
P2093
Ae S Youngpairoj
Debra R Adams
Ellen N Kersh
J Gerardo Garcia-Lerma
James Mitchell
Janet McNicholl
Mian-er Cong
R Michael Hendry
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0019295
P407
P577
2011-04-26T00:00:00Z